| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Aryeh Jason is a Director at Orchestra BioMed Holdings, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 13 buys and 3 sells.
Estimated insider holdings value: $16.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 10,000 | $170.81 | $1,708,087.72 | -4.5% | +16.0% | - | |
| Sep 19, 2025 | OBIO Orchestra Biomed Holdings, Inc. | Director | Buy | 1,000 | $2.45 | $2,450.00 | +0.9% | +77.9% | - | |
| Sep 3, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Buy | 750 | $87.01 | $65,257.50 | +1.1% | - | - | |
| Aug 5, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Buy | 746 | $90.01 | $67,145.97 | +1.1% | - | - | |
| Jul 31, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Buy | 4,004 | $99.22 | $397,286.75 | +2.1% | - | - | |
| Jun 11, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Buy | 250 | $107.01 | $26,752.50 | +0.4% | - | - | |
| May 31, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Buy | 1,000 | $109.51 | $109,510.00 | +0.6% | - | - | |
| May 20, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Buy | 250 | $112.01 | $28,002.50 | +0.4% | - | - | |
| May 14, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Buy | 250 | $112.51 | $28,127.50 | +0.4% | - | - | |
| Mar 13, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Buy | 202 | $112.51 | $22,727.02 | +0.4% | - | - |